Literature DB >> 25567380

Understanding ARDS-associated fibroproliferation.

Gianfranco Umberto Meduri1, Mahmoud A Eltorky.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25567380     DOI： 10.1007/s00134-014-3613-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Molecular evolution of the NF-kappaB signaling system.

Authors:  Robert Friedman; Austin L Hughes
Journal:  Immunogenetics       Date:  2002-01-09       Impact factor: 2.846

Review 3.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 4.  The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment.

Authors:  G U Meduri
Journal:  Eur Respir J       Date:  1996-12       Impact factor: 16.671

Review 5.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review.

Authors:  A L Katzenstein; C M Bloor; A A Leibow
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

6.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

7.  Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies.

Authors:  Arnaud W Thille; Andrés Esteban; Pilar Fernández-Segoviano; José-María Rodriguez; José-Antonio Aramburu; Patricio Vargas-Errázuriz; Ana Martín-Pellicer; José A Lorente; Fernando Frutos-Vivar
Journal:  Lancet Respir Med       Date:  2013-05-15       Impact factor: 30.700

8.  Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids.

Authors:  G Umberto Meduri; Muthiah P Muthiah; Pierluigi Carratu; Mahmoud Eltorky; George P Chrousos
Journal:  Neuroimmunomodulation       Date:  2005       Impact factor: 2.492

9.  Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.

Authors:  G U Meduri; E A Tolley; A Chinn; F Stentz; A Postlethwaite
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

Review 10.  Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome.

Authors:  G Umberto Meduri
Journal:  Crit Care       Date:  2001-11-09       Impact factor: 9.097
View more
  14 in total

Review 1.  Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.

Authors:  G Umberto Meduri; Lisa Bridges; Mei-Chiung Shih; Paul E Marik; Reed A C Siemieniuk; Mehmet Kocak
Journal:  Intensive Care Med       Date:  2015-10-27       Impact factor: 17.440

2.  Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment.

Authors:  Gianfranco Umberto Meduri
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

3.  Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.

Authors:  Djillali Annane; Stephen M Pastores; Bram Rochwerg; Wiebke Arlt; Robert A Balk; Albertus Beishuizen; Josef Briegel; Joseph Carcillo; Mirjam Christ-Crain; Mark S Cooper; Paul E Marik; Gianfranco Umberto Meduri; Keith M Olsen; Sophia Rodgers; James A Russell; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2017-09-21       Impact factor: 17.440

4.  Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway.

Authors:  Juan Li; Mei-Xia Xu; Zhong Dai; Tao Xu
Journal:  Curr Med Sci       Date:  2021-01-11

Review 5.  Computational lung modelling in respiratory medicine.

Authors:  Sunder Neelakantan; Yi Xin; Donald P Gaver; Maurizio Cereda; Rahim Rizi; Bradford J Smith; Reza Avazmohammadi
Journal:  J R Soc Interface       Date:  2022-06-08       Impact factor: 4.293

6.  Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis.

Authors:  Yu-Qing Cui; Xian-Fei Ding; Huo-Yan Liang; Dong Wang; Xiao-Juan Zhang; Li-Feng Li; Quan-Cheng Kan; Le-Xin Wang; Tong-Wen Sun
Journal:  World J Emerg Med       Date:  2021

Review 7.  Microphysiological systems modeling acute respiratory distress syndrome that capture mechanical force-induced injury-inflammation-repair.

Authors:  Hannah Viola; Jonathan Chang; Jocelyn R Grunwell; Louise Hecker; Rabindra Tirouvanziam; James B Grotberg; Shuichi Takayama
Journal:  APL Bioeng       Date:  2019-11-22

8.  Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype.

Authors:  Xiaowei Bao; Xiandong Liu; Na Liu; Shougang Zhuang; Qian Yang; Huijuan Ren; Dongyang Zhao; Jianwen Bai; Xiaohui Zhou; Lunxian Tang
Journal:  Respir Res       Date:  2021-07-03

Review 9.  Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.

Authors:  Andreas Schwingshackl; Gianfranco Umberto Meduri
Journal:  Front Pediatr       Date:  2016-06-14       Impact factor: 3.418

Review 10.  The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.

Authors:  Lucy A Murtha; Michael J Schuliga; Nishani S Mabotuwana; Sean A Hardy; David W Waters; Janette K Burgess; Darryl A Knight; Andrew J Boyle
Journal:  Front Physiol       Date:  2017-10-12       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.